NCT00575055 Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Carrier) Status COMPLETED Phase PHASE3
NCT00574873 Compare Bosutinib To Imatinib In Subjects With Newly Diagnosed Chronic Phase Philadelphia Chromosome Positive CML Status COMPLETED Phase PHASE3
NCT00574132 Bapineuzumab in Patients With Mild to Moderate Alzheimer's Disease (ApoE4 Non-Carrier) Status COMPLETED Phase PHASE3
NCT00573261 A Randomized Double-Blind Study Testing the Effects of Pregabalin on Diabetic Neuropathy Status COMPLETED Phase PHASE4
NCT00572559 Microbiologic Response With Linezolid And Vancomycin In Ventilator-Associated Pneumonia Due To Methicillin Resistant Staphylococcus Aureus Status COMPLETED Phase PHASE4
NCT00572455 Safety and Efficacy of PF-04217329 in Patients With Glaucoma or Elevated Eye Pressure. Status COMPLETED Phase PHASE2
NCT00571805 Study of Varencline Effects on Cigarette Smoking Reward and Craving During a Model of Brief Quit Attempt Status WITHDRAWN Phase PHASE1/PHASE2
NCT00571064 The Effectiveness And Safety Of Donepezil Hydrochloride (E2020) In Subjects With Mild To Severe Alzheimer's Disease Residing In An Assisted Living Facility Status COMPLETED Phase PHASE4
NCT00570544 Tiotropium Induced Bronchodilation in Lung CT Scored Emphysema Status COMPLETED Phase N/A
NCT00570128 Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (HCl) (Aricept) In Treating Cognitive Dysfunction Exhibited By Children With Down Syndrome Status COMPLETED Phase PHASE2
NCT00570063 Double Blind, Randomized, 3 Week Inpatient Study To Evaluate The Safety & Efficacy Of PF-02545920 Compared With Placebo Status TERMINATED Phase PHASE2
NCT00569972 A Randomized, Double Blind, Parallel Group, Placebo Controlled, Multicenter Outpatient Trial Of PD 0200390 In Adults With Primary Insomnia Status COMPLETED Phase PHASE2
NCT00569946 Study Of AG-013736 (Axitinib) As Second-Line Treatment In Patients With Metastatic Renal Cell Cancer (mRCC) Status COMPLETED Phase PHASE2
NCT00567203 A Study Of Adjunctive Treatment Of Cognitive Deficits In Schizophrenia Status COMPLETED Phase PHASE1
NCT00566397 A Phase 2 Study Evaluating The Efficacy And Safety Of PF 04494700 In Mild To Moderate Alzheimer's Disease Status COMPLETED Phase PHASE2